Welcome to our dedicated page for Tradewinds Universal SEC filings (Ticker: TRWD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Tradewinds Universal's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Tradewinds Universal's regulatory disclosures and financial reporting.
Tradewinds Universal (TRWD) reported very small revenue and a sharply higher loss for the quarter and six months ended June 30, 2026. Revenue was $25,000 for the quarter and $46,800 for the first half of 2026, while net loss for the six-month period was $2,992,201, driven largely by $2,858,498 of consulting expense, including $2,801,200 of stock-based compensation for 79,000,000 shares issued for services.
Cash and cash equivalents were only $8,636 at June 30, 2026, with $141,002 of cash used in operating activities in the first half and an accumulated deficit of $4,175,269. Management states these conditions raise substantial doubt about the company’s ability to continue as a going concern. To support liquidity, Tradewinds entered a common stock purchase (equity line of credit) agreement permitting sales of up to $10,000,000 of common stock and issued 5,920,000 shares under this facility for aggregate consideration of $182,810, which remained unpaid and recorded as a stock subscription receivable.
Share count increased significantly, from 42,690,580 at December 31, 2025 to 129,810,580 at June 30, 2026, including 75,000,000 shares issued to the CEO for services. As of June 30, 2026, the company had $92,000 of liabilities (accounts payable and a loan payable), and 3,146,667 warrants outstanding. Management identified a material weakness in internal control over financial reporting due to a lack of segregation of duties.
Tradewinds Universal notified regulators that its Quarterly Report on Form 10-Q for the period ended June 30, 2026 will be filed late. The company states it needs additional time to compile and review information to ensure adequate disclosure. It expects to submit the 10-Q within the 5-day extension period permitted under Rule 12b-25 for late quarterly reports.
Tradewinds Universal filed a current report describing a board change and a major update to its capital structure. On June 5, 2026, the board appointed Alan Chang, founder of the Peppermint Hippo™ brand, as a director, to serve until the next annual shareholder meeting or earlier departure.
Separately, on May 15, 2026, holders of a majority of the company’s outstanding voting shares approved, and the board adopted, an amendment to Article V of the Articles of Incorporation to increase authorized common stock from 75,000,000 to 250,000,000 shares, par value $0.001 per share. Authorized preferred stock remains at zero. The amendment was filed with the Wyoming Secretary of State on June 5, 2026 and became effective upon filing.
Tradewinds Universal reported results for the quarter ended March 31, 2026 with revenue of $21,800, up from $12,972 a year earlier, driven mainly by higher licensing and distribution activity.
Operating expenses rose sharply to $147,141, leading to a net loss of $125,341 versus a $1,112 loss in the prior-year quarter. Cash used in operating activities was $76,041, and cash on hand was $15,597 at period end.
The company raised $50,000 from issuing 1,000,000 shares and obtained a $25,000 loan, ending with total assets of $283,992 and stockholders’ equity of $231,992. Management disclosed that recurring losses and limited cash resources raise substantial doubt about Tradewinds Universal’s ability to continue as a going concern.
Tradewinds Universal is registering 20,000,000 shares of common stock for resale by RH2 Equity Partners under a committed equity line of credit. These shares relate to a purchase agreement allowing RH2 to buy stock over time.
Tradewinds will not receive proceeds from RH2’s resale, but may raise up to $10,000,000 by selling newly issued shares to RH2 after effectiveness. Shares outstanding could rise from 42,690,580 as of December 31, 2025 to 62,690,580 if all registered shares are issued. The company reports modest 2025 revenue of $133,222, a net loss of $892,877, and a going concern warning, and is shifting from insect-based nutrition products toward licensing and a potential nightlife and hospitality expansion via a non-binding Peppermint Hippo LOI.
Tradewinds Universal is registering 20,000,000 shares of common stock for resale by RH2 Equity Partners under a committed equity facility. The company itself is not selling shares in this prospectus, but may sell up to $10,000,000 of stock to RH2 at its discretion over 24 months.
As of December 31, 2025, Tradewinds had 42,690,580 shares outstanding and operates edible insect protein products and a licensed canine pain-relief formula, while exploring a nightlife and hospitality expansion via a non-binding Peppermint Hippo LOI. 2025 revenue was $133,222, with a net loss of $892,877, and auditors have raised substantial doubt about its ability to continue as a going concern.
The filing highlights very early-stage operations, heavy reliance on CEO Andrew Read, liquidity risk, penny-stock trading on OTCMarkets under “TRWD,” and the potential for significant dilution and price pressure as RH2 resells shares purchased at a discount to market.
Tradewinds Universal, Inc. reports a larger 2025 loss and files an amended annual report to add auditor consent without changing prior disclosures. Revenue fell to about $133,222, mainly from licensing and distribution rights, down from $171,596 in 2024 as it exited physical product sales.
Operating expenses jumped to roughly $1,026,099, driven by about $886,105 in consulting and professional costs, leading to a net loss of approximately $892,877 and an accumulated deficit near $1,183,067. Cash stood at $16,638 within total assets of about $307,333, and auditors highlighted substantial doubt about the company’s ability to continue as a going concern. The company shifted toward licensing, acquired additional intangible assets, and secured a $10.0 million common stock purchase agreement to access future equity financing.
Tradewinds Universal, Inc. reported that its recently filed Annual Report on Form 10-K for the year ended December 31, 2025 did not include a required auditor consent. The missing consent relates to the report of Astra Audit & Advisory, the company’s independent registered public accounting firm for December 31, 2024.
The company is working with Astra Audit & Advisory to obtain this consent as promptly as practicable. Once received, it plans to file the consent with the SEC and may amend the 2025 Form 10-K solely to add the consent. The company is also evaluating how the omitted consent affects any effective registration statements that incorporate the original Form 10-K by reference.
Tradewinds Universal reported 2025 revenue of $133,222, down from $171,596 in 2024, as it shifted away from physical protein bar sales toward licensing and distribution rights. With no cost of goods sold, gross margin reached 100%, but operating expenses surged to $1,026,099, driven mainly by consulting and stock-based compensation.
The company recorded a 2025 net loss of $892,877 and ended the year with total assets of $307,333, including $216,500 in intangible assets, and cash of $16,638. Accumulated deficit rose to $1,183,067, and auditors highlighted substantial doubt about its ability to continue as a going concern.
Strategically, Tradewinds is focusing on licensing its canine pain relief formula, selling distribution and licensing rights, and pursuing new verticals. In August 2025 it signed a Letter of Intent with Peppermint Hippo™ to enter the nightlife and hospitality sector. Subsequent to year-end, it entered a $10.0 million common stock purchase agreement with RH2 Equity Partners to provide potential future equity funding.